Name | ANTI-CD154 |
---|
Description | Toralizumab (IDEC-131) is a humanized monoclonal antibody (mAb) against CD40L (CD154) comprised of human gamma 1 heavy chains and human kappa light chains. Toralizumab binds specifically to human CD40L on T cells, thereby preventing CD40 signaling. Toralizumab, a immunosuppressive drug, has the potential for active systemic lupus erythematosus (SLE) research[1][2]. |
---|---|
Related Catalog | |
Target |
CD40L |
References |
Appearance | lyophilized powder |
---|---|
Storage condition | −20°C |